Recruiting

FMTFMT Methodology and Patient Registry for Long-Term Safety and Effectiveness

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe the long-term safety and effectiveness of Fecal Microbiota Transplantation (FMT) by monitoring disease re-occurrence after treatment and any related adverse events, such as surgeries, infections, hospitalizations, life-threatening events, deaths, and newly diagnosed diseases.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Bacterial Infections and Mycoses+2

+ Bacterial Infections

+ Clostridium Infections

+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: September 2017
See protocol details

Summary

Principal SponsorAmerican Gastroenterological Association
Study ContactSonya Serra, MScMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 20, 2017

Actual date on which the first participant was enrolled.

This study is about the Fecal Microbiota Transplant (FMT), a procedure that involves transplanting healthy bacteria from a donor into a patient's gut. The study aims to enroll 4,000 patients across 75 sites in North America who are undergoing FMT. The importance of this study lies in understanding the effectiveness and safety of FMT, as it could potentially offer a new treatment approach for various gut-related conditions. The study will collect information on the FMT methodology used, the reasons for FMT, and the patients' health status before the procedure. After the FMT, patients will be regularly monitored for up to 10 years. This includes follow-ups with the healthcare provider at 1 month, 6 months, 1 year, and 2 years post-FMT, and direct communication with patients annually until the 10th year. The study will assess the short-term and long-term safety and effectiveness of FMT. The effectiveness will be measured by monitoring disease re-occurrence after treatment. Safety will be evaluated by tracking any treatment-related adverse events, such as surgeries, infections, hospitalizations, life-threatening events, death, and newly diagnosed diseases.

Official TitleFecal Microbiota Transplant National Registry
NCT03325855
Principal SponsorAmerican Gastroenterological Association
Study ContactSonya Serra, MScMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

4000 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Bacterial Infections and MycosesBacterial InfectionsClostridium InfectionsInfectionsGram-Positive Bacterial Infections

Criteria

4 inclusion criteria required to participate
Receiving FMT or other gut-related microbiota product within 90 days after providing consent

Providing stool sample for FMT

Access to internet and/or telephone

Ability to give informed consent

1 exclusion criteria prevent from participating
Incarceration

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 53 locations

Recruiting

Stanford University

Redwood City, United StatesOpen Stanford University in Google Maps
Recruiting

University of Kansas Medical Center Research Institute

Kansas City, United States
Recruiting

Ochsner

New Orleans, United States
Recruiting

Boston Children's Hospital

Boston, United States
Recruiting
53 Study Centers